Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants is a research paper published in Genes Chromosomes and Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P50 CA62924
National Cancer Institute
Grant: R00 CA190889
NCI NIH HHS
Grant: K99 CA190889
NCI NIH HHS
Grant: P50 CA062924
National Institutes of Health
Grant: 2R01DK060694-11
The Prrx-1 transcription factor in pancreatic ductal biology
National Institutes of Health
Grant: 4R00CA190889-03
Integrative Analyses to Identify Pancreatic Cancer Susceptibility Genes
National Institutes of Health
Grant: 5R01CA057345-02
CHARACTERIZATION OF GENES FROM THE FAP LOCUS
National Institutes of Health
Grant: 5P50CA062924-25
SPORE in Gastrointestinal Cancers
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 5R01CA154823-09
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
National Institutes of Health
Grant: 5P50CA102701-10
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer
National Institutes of Health
Grant: 5R01CA097075-05
Pancreatic Cancer Genetic Epidemiology Consortium
Ontario Institute for Cancer Research
Lustgarten Foundation
FWCI
0.24
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals